Panaxium

Focus: Panaxium is a micro-scale biotechnology company focused on brain-machine interface technology, headquartered in Aix-en-Provence, France. With 1-50 employees, the company operates as an early-stage biotech venture.

Unknown Medical Devices

Profile data last refreshed 21h ago · AI intelligence enriched 2w ago

Employees

1-50

Open Jobs

About Panaxium

AI assessmentNot Hiring

No open roles listed right now. Follow Panaxium to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

PANAXIUM MicroECoG

Glioma

N/A

Clinical Trials (1)

NCT06408428Glioma Intraoperative MicroElectroCorticoGraphy

N/A

Help build intelligence for Panaxium

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on cutting-edge brain-machine interface (BMI) technology with meaningful medical applications in neurosurgery and oncology
Small, agile team environment (1-50 employees) enables hands-on involvement across multiple functions and accelerated learning
Access to emerging therapeutic area with limited competition and high differentiation potential

Watch Out For

Extreme early-stage risk: single clinical trial, no revenue, funding status unknown, and no published data on company track record
Micro-cap scale (1-50 employees) limits career infrastructure, mentorship depth, and job security if funding dries up
Only 3 active job openings and micro-scale operations suggest limited growth headroom and narrow internal mobility

Generated by Claude from Panaxium's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Top TAs: Neurology, Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

1 pipeline

Oncology

1 pipeline

Marketed

Pipeline